SCHEMBL6787331

SCHEMBL6787331

O=[N+]([O-])c1ccc(OCCCc2ccccn2)nc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.57
KMT2A Q03164 5/20 0.51
MEN1 O00255 2/20 0.51
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 2/20 0.44
GABRA5 P31644 1/20 0.43
HSPB1 P04792 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
CYP19A1 P11511 2/20 0.42
CYP11B1 P15538 2/20 0.42
CYP11B2 P19099 2/20 0.42
PKM P14618 1/20 0.41
GAA P10253 1/20 0.41
APOBEC3A P31941 1/20 0.40
HTT P42858 1/20 0.40
APOBEC3G Q9HC16 1/20 0.40
LMNA P02545 1/20 0.40
HRH1 P35367 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6500018 0.93 POLB (0.58) POLBKMT2AMEN1NPC1RAB9A
SCHEMBL30716904 0.85 POLB (0.54) POLBKMT2AMEN1NPC1RAB9A
SCHEMBL7537239 0.85 POLB (0.54) POLBKMT2AMEN1NPC1RAB9A
SCHEMBL15399370 0.82 CYP19A1 (0.56) POLBKMT2AMEN1ALDH1A1GABRA5
SCHEMBL6792817 0.76 HRH1 (0.50) KMT2AMEN1ALDH1A1L3MBTL1LMNA
SCHEMBL4271251 0.76 HSPB1 (0.50) POLBKMT2AMEN1NPC1RAB9A
SCHEMBL3333575 0.76 MAPT (0.58) KMT2AMEN1NPC1RAB9AKDM4E
SCHEMBL14549594 0.76 HSPB1 (0.50) POLBKMT2AMEN1NPC1RAB9A
SCHEMBL6793846 0.75 KMT2A (0.62) POLBKMT2AMEN1NPC1RAB9A
SCHEMBL31636995 0.75 HSPB1 (0.49) POLBKMT2AMEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-03-25 US disclosed
CN-1478077-A Benzamide compounds as APO B secretion inhibitors ����ҩƷ��ҵ��ʽ���� 2004-02-25 CN disclosed
EP-1326835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-07-16 EP disclosed
WO-2002028835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-04-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors APOB, APOL1, SCARB1 POLB 1470/4885KMT2A 2457/4885MEN1 2426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.